stocktitan.netSEP 111 min read$VREX

Varex Imaging (NASDAQ: VREX) filer plans $2.4M stock sale

Varex Imaging (VREX) shareholder Shubham Maheshwari plans to sell 130,000 shares, valued at approximately $2.4M, under Rule 144. The sale is tied to a stock option exercise and is expected to occur on September 11, 2026.

Original reporting

stocktitan.net

Published Sep 11, 2026, 8:24 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Sep 13, 2026, 2:09 AM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

AlphAI market briefFinancial news

Primary signal

$VREX

Neutral

high confidence

Mentioned

$VREX

Relevance

4/10

AlphAI data visualization · based on stocktitan.net

Decision brief

The 30-second read

$VREXNeutralLow

Why it matters

The sale is modest and unlikely to move the stock significantly.

Market read

Routine insider sale with limited market effect.

Timing

Sep 11 2026 transaction date

Relevance 4/10Novelty 4/10Timing: Sep 11 2026 transaction date

Background

Rule 144 filing indicates a planned insider sale of VREX shares.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$VREXNeutralHigh confidence

Context

Rule 144 filing to sell 130,000 shares worth ~$2.4M on Sep 11, 2026.

Expected impact

Minimal downward pressure, likely negligible.

Evidence & confidence

Small transaction relative to market cap; typical insider sale.

Key entities

company
Varex Imaging Corp
Issuer of the shares being sold.
insider
Shubham Maheshwari
Filing party planning the share sale.

Read at source ← All news

AUG 28

$VREXHighAI 9/10

Teledyne to Acquire Varex Imaging in $1.1 Billion Deal – Metrology and Quality News

Teledyne Technologies (TDY) will acquire Varex Imaging (VREX) for $1.1 billion, including net debt and equity awards. The deal, approved by both boards, is expected to close in early 2027. Varex's X-ray technologies complement Teledyne's offerings, with minimal product overlap. The acquisition aims to accelerate Varex's product development and adoption.

metrology.news2 min

AUG 24

$TDYHighAI 9/10

Los Angeles Business Journal

Teledyne Technologies (TDY) agreed to acquire Varex Imaging (VREX) for $1.1B, or $18.90 per share in cash. The deal is expected to close in 2027. Varex's X-ray imaging tech complements Teledyne's portfolio, according to Varex's CEO. Teledyne has previously acquired firms in the healthcare sector, including Dalsa Corp. and DD-Scientific.

labusinessjournal.com2 min

AUG 16

$TDYHighAI 9/10

Strategic Consolidation in Medical Imaging: Analysis of Teledyne Technologies' Acquisition of Varex Imaging

Teledyne (NYSE: TDY) agreed to buy Varex Imaging (NASDAQ: VREX) in an all-cash merger for $18.90 per share, valuing the deal at about $1.1 billion including net debt and equity awards. Boards approved unanimously; closing expected early 2027. Varex reported Q3 FY2026 revenue of $210.5M and GAAP net income of $15.7M.

healthcare.digital7 min

AUG 15

$LNTHMed

Weekly Buzz: LNTH, CBLL Win FDA Nod; AURA Cuts Jobs; TDY Buys VREX; CGEM, DFTX Meet Trial Goals

Biopharma roundup reported FDA/EC approvals and trial updates for Lantheus (LNTH) TAUKLARIFY, Ceribell (CBLL) AI EEG algorithms, Labcorp (LH) PGDx CDx, and EU/UK approvals for Galderma (GDERF) Restylane Shaype and Rhythm (RYTM) IMCIVREE. GRAIL (GRAL) faces an FDA panel on Sept. 23. Teledyne (TDY) to buy Varex (VREX) for about $1.1B; Aura (AURA) cut 20% staff.

rttnews.com7 min

AUG 14

$TDYMedAI 9/10

Why Is Teledyne Technologies (TDY) Paying a 52% Premium for Varex (VREX)?

Teledyne Technologies (NYSE:TDY) agreed to acquire Varex Imaging (NASDAQ:VREX) for $18.90 per share in cash, a 52% premium to Varex’s unaffected close. The deal values Varex at about $1.1 billion including equity awards and net debt. Varex jumped 48.5% to $18.42 on Aug. 10; TDY fell slightly. Teledyne cited synergies but did not quantify EPS accretion.

yahoo.com6 min